Allied Health & Imaging · Independent exam preparation
Registered Phlebology Sonographer (RPhS) Study Guide
Practise venous ultrasound decisions: distinguish thrombosis, reflux and lymphatic disease, optimize duplex studies, and assess treatment safety for CCI RPhS.
By CertMedbry · Updated 1 November 2026
Learn to select appropriate venous studies, distinguish obstruction from reflux, recognize urgent findings, and connect treatment choices with anatomy and patient risk. These 60 selected concepts develop clinical reasoning across all five RPhS domains, supported by 20 original practice questions and 20 recall cards. The official CCI knowledge list and task outline define the full examination scope.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination and qualification pathway does this guide follow?
The examination is CCI’s Registered Phlebology Sonographer (RPhS). RPhS1 is the eligibility reference for this guide: an active RVS or RVT credential, six months of qualifying venous ultrasound employment, and 36 relevant CEUs within the preceding four years. RPhS2 and RPhS3 provide education-based entry routes; RPhS567 addresses licensed physician associates or nurse practitioners; RPhS5–7 address physicians. These routes lead to the same RPhS examination. RPhS is not an RN or NP licensure examination, and the credential does not independently establish a jurisdiction’s clinical practice authority.
How many questions are scored, and how much time is available?
CCI lists 170 questions: 150 scored and 20 unidentified, randomly distributed unscored questions. The three-hour appointment includes two hours and 50 minutes for answering questions and ten minutes for the tutorial and post-examination survey.
Which item styles and delivery method does CCI describe?
The examination is computer based and delivered through Pearson testing centers. CCI’s detailed Examination Details section lists single-answer multiple choice, multiple response, hot spot, and drag-and-place items. A later section on the same page summarizes questions as four-option single-answer items, so the page is internally inconsistent about formats; prepare for the explicitly listed formats and follow each item’s instructions. CCI’s examination page does not establish computer-adaptive delivery. This guide’s questions are independent four-option drills.
Which blueprint applies to this guide?
This guide uses the present matrix documented on October 15, 2026 and still displayed in CCI’s November 1, 2026 page: Maintain Information, Facility, and Safety 9%; Patient Diagnosis 27%; Performance of Diagnostic Testing 36%; Conservative Treatment/Therapy of Patients 9%; and Minimally Invasive and Invasive Treatment of Patients 20%. These published approximate values sum to 101%, although CCI labels the total 100%. The 60 concepts allocate 5, 16, 22, 5, and 12 concepts respectively; each 20-item practice set allocates 2, 5, 7, 2, and 4 items.
Registered Phlebology Sonographer (RPhS) — CCI · Registered Phlebology Sonographer Examination Overview — June 2022
What changes around February 1, 2027?
CCI separately labels preparation information for after February 1, 2027, with weights of 7%, 25%, 38%, 10%, and 20% across the same five domains. CCI also announces testing only during February and August beginning February 1, 2027. This guide retains the present matrix. Candidates testing during the transition should use the preparation section applicable to their examination date and the dates in their Authorization to Test. The June 2022 booklet’s publication date is verified; a separate effective date for the present online matrix is not supplied.
Registered Phlebology Sonographer (RPhS) — CCI · Registered Phlebology Sonographer Examination Overview — June 2022
What fee and passing score are verified?
CCI’s November 1, 2026 information lists a $365 USD examination fee, including a $100 nonrefundable application-processing component. Scores use a 0–900 scale, with 650 required to pass. A scaled score of 650 is not a percentage-correct requirement. These practice drills do not predict passing.
How should the historical overview and clinical references be used?
The June 2022 overview corroborates examination scope and the present domain weights. Its former RPhS4 qualification route was sunset for first-time applications beginning July 1, 2023. Use the current CCI page for eligibility and scheduling. Clinical recommendations are supported by clinical guidelines, practice parameters, regulatory labeling, or primary research; the examination outline establishes scope. ASH’s [diagnosis teaching slides](https://www.hematology.org/-/media/hematology/files/clinicians/guidelines/vte/ash-teaching-slide-setvtediagnosispdffinal71923.pdf), linked from its diagnosis guideline page, explain the probability-specific DVT pathways used here.
Registered Phlebology Sonographer Examination Overview — June 2022 · Registered Phlebology Sonographer (RPhS) — CCI · ASH VTE Guidelines: Diagnosis of Venous Thromboembolism - Hematology.org
RPhS is CCI’s registry-level credential for professionals working in venous ultrasound. This independently authored guide addresses that venous specialty examination and uses the present examination matrix, corroborated by the June 2022 overview.
Outline used: CCI's current online Examination Matrix and Task List, reviewed as of 2026-10-15. The present matrix matches the June 2022 Examination Overview; the webpage does not give a separate effective date for that present matrix. CCI separately identifies an examination-preparation outline for after February 1, 2027. This guide uses the present matrix.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Maintain Information, Facility, and Safety9%
1.How do patient identifiers prevent a correct study from reaching the wrong record?
Confirm two independent patient identifiers, such as full name and date of birth, against the order and examination record before acquiring images. A room number identifies a location rather than a person. Resolve discrepancies before proceeding because an accurate image attached to the wrong patient can produce an incorrect treatment decision. Recheck the intended examination and laterality, and preserve the association between the verified patient, acquired images, and final report throughout documentation.
Apply it
Two patients with similar names arrive for venous studies. Ask each to state their name and date of birth, compare both with the order, and resolve a mismatched birth date before selecting the imaging record.
Common pitfall: Recognizing a familiar face or accepting a room assignment feels efficient, but neither supplies the independent identity checks needed to prevent record-selection errors.
AIUM: Policies and Procedures Safeguarding Patients and Personnel
2.How should hand hygiene and transducer reprocessing work together?
Hand hygiene interrupts transfer of organisms between the clinician, equipment, and patient. Perform it before patient contact and after glove removal; gloves do not replace it. Clean a transducer before disinfection because retained organic material can interfere with processing. Equipment contacting intact skin generally requires low-level disinfection, whereas contact with mucous membranes or nonintact skin requires at least high-level disinfection. Select a compatible process based on actual contact and manufacturer instructions.
Apply it
After scanning intact calf skin, the sonographer removes gloves and prepares for another patient. Perform hand hygiene, remove gel and visible soil, and complete the transducer’s compatible low-level disinfection process before reuse.
Common pitfall: A clean-looking probe may still carry organisms. Wiping away gel alone is cleaning, and applying disinfectant over residual debris does not complete reliable reprocessing.
CDC: Clinical Safety — Hand Hygiene for Healthcare Workers · CDC Recommendations for Disinfection and Sterilization in Healthcare Facilities
3.Why does percutaneous ultrasound guidance require sterile single-use gel?
A percutaneous procedure can carry organisms from gel or the skin surface into deeper tissue through the needle tract. CDC investigations link contaminated nonsterile ultrasound gel with invasive Burkholderia infections. Use sterile, single-use gel for percutaneous procedures and maintain the procedure’s sterile field. A sterile probe cover addresses the covered transducer surface, but it does not sterilize gel placed outside the cover or eliminate the need for appropriate transducer reprocessing.
Apply it
A team prepares ultrasound-guided venous access with a sterile probe cover but a refillable gel bottle. Replace the gel with a sterile single-use product before creating the needle-entry field and beginning guidance.
Common pitfall: A sterile cover can create false reassurance. Nonsterile gel used beneath an intended puncture site remains a contamination source despite the covered probe.
CDC: Burkholderia Infections Associated with Contaminated Ultrasound Gel
4.How does workstation positioning reduce sonographer injury?
Sustained shoulder abduction, reaching, wrist deviation, and forceful gripping increase musculoskeletal loading during sonography. Bring the patient close, adjust bed and chair height, position the monitor within a comfortable viewing angle, and support the scanning arm when feasible. Reposition the patient or move around the bed rather than sustaining a long reach. Inspect cables and equipment before use so a damaged component or awkward cable arrangement does not add avoidable risk.
Apply it
During a prolonged reflux examination, the sonographer reaches across the patient with an elevated shoulder. Move to the nearer side, adjust bed height, bring the console within reach, and resume with a more neutral arm position.
Common pitfall: Finishing a difficult segment without repositioning may seem faster, but repeated static loading accumulates even when no single movement produces immediate pain or injury.
5.How does quality improvement identify the cause of discordant venous reports?
Quality review should examine whether the study was appropriate, technically complete, accurately interpreted, and reported completely and promptly. A discrepancy is a signal to examine the process rather than assume one individual is responsible. Compare acquisition protocols, images, measurements, interpretation criteria, and communication records. Choose a corrective action that addresses the demonstrated cause, then reassess subsequent cases. Securely archived images and reports make this comparison possible and preserve an auditable clinical record.
Apply it
Two readers repeatedly disagree about reflux. Review patient position, provocation recordings, measured durations, and reporting criteria before arranging targeted retraining. Reaudit comparable examinations afterward to determine whether the disagreement rate actually decreases over time.
Common pitfall: Counting amended reports alone measures an outcome without explaining its cause. Reader education cannot correct missing acquisition data or inconsistent examination positioning by itself.
IAC Standards and Guidelines for Vascular Testing Accreditation — August 3, 2026
Patient Diagnosis27%
6.When do symptoms during a venous visit require emergency escalation?
Pulmonary embolism may cause sudden unexplained dyspnea, pleuritic chest pain, tachycardia, hemoptysis, lightheadedness, or syncope. It can occur without recognizable leg symptoms. New cardiopulmonary symptoms during a venous appointment therefore require immediate clinical assessment through the facility’s emergency pathway rather than completion of a routine leg study first. A lower-extremity ultrasound evaluates venous thrombosis in its examined territory; a negative result does not independently exclude pulmonary embolism or establish cardiopulmonary stability.
Apply it
A patient awaiting a reflux scan develops sudden breathlessness and chest pain after recent hospitalization. Stop routine testing, activate the facility’s emergency response, and communicate the symptoms and recent risk history to the responding team.
Common pitfall: Waiting to find a leg clot before escalating delays assessment. Neither absent calf pain nor a previously negative leg ultrasound excludes pulmonary embolism.
7.Which history findings increase concern for venous thromboembolism?
Venous thromboembolism risk rises with factors that promote slowed venous flow, vessel injury, or increased clotting tendency. Relevant history includes recent surgery or hospitalization, prolonged immobility, active cancer, previous VTE, pregnancy or the postpartum period, estrogen exposure, and inherited risk. Multiple factors can coexist and increase concern. The history informs clinical probability and test selection, but a risk factor alone does not diagnose DVT; symptoms and objective testing remain necessary.
Apply it
A patient with new unilateral swelling recently underwent major surgery and has been largely immobile. Document the timing and previous clot history, communicate the elevated concern, and support a probability-based diagnostic pathway rather than attributing swelling to inactivity.
Common pitfall: A young age or absent family history can be reassuring but does not cancel strong acquired risks such as surgery, immobility, cancer, or estrogen exposure.
8.Why must clinical probability precede interpretation of a DVT test?
A test result changes an existing probability of disease; it does not have the same meaning in every patient. A validated clinical decision rule organizes relevant symptoms and risk findings before testing. In low-probability settings, a negative highly sensitive D-dimer can exclude DVT within an appropriate pathway. Higher probability generally requires ultrasound-based assessment, and a negative limited examination may need follow-up. Clinical probability guides the sequence and interpretation of tests rather than replacing objective confirmation.
Apply it
Two patients have negative initial proximal studies, but one has minimal risk and an alternative diagnosis while the other has marked unilateral swelling and strong risk factors. Their next steps differ because their remaining probabilities differ.
Common pitfall: Treating a negative result as equally definitive in every patient ignores pretest probability, examination extent, and whether the selected diagnostic pathway has been completed.
ASH VTE Guidelines: Diagnosis of Venous Thromboembolism - Hematology.org
9.What does a positive D-dimer establish after surgery?
D-dimer reflects breakdown of cross-linked fibrin and is sensitive to several processes besides acute venous thrombosis. Recent surgery, hospitalization, pregnancy, and other conditions frequently produce positive results, reducing its usefulness for excluding disease efficiently in those populations. A positive result does not locate a clot or confirm DVT. It requires interpretation within clinical probability and further diagnostic testing when indicated. A negative result is useful only within a validated pathway using an appropriately sensitive assay.
Apply it
A postoperative patient has calf swelling and an elevated D-dimer. Explain that the blood result cannot distinguish postoperative fibrin turnover from DVT, and proceed with the indicated ultrasound assessment rather than labeling the result diagnostic.
Common pitfall: Equating a markedly positive result with a large clot confuses a nonspecific laboratory signal with anatomical evidence of thrombosis and its extent.
ASH VTE Guidelines: Diagnosis of Venous Thromboembolism - Hematology.org · ASH: Testing for Blood Clots — Patient Version
10.How do probability and examination extent determine follow-up after negative DVT ultrasound?
A proximal examination may miss isolated distal thrombosis that could extend. In ASH’s intermediate-probability pathway, a technically adequate negative whole-leg examination can complete testing, whereas a negative proximal examination requires serial proximal ultrasound when no alternative diagnosis explains symptoms. In the high-probability pathway, an initially negative proximal or whole-leg examination should be followed by serial ultrasound if no alternative diagnosis is identified. Serial testing means one additional ultrasound approximately one week later. A technically limited examination requires further assessment rather than interpretation as an adequate negative study.
Apply it
A high-probability patient has persistent unilateral swelling, a negative whole-leg examination, and no alternative explanation. Arrange serial assessment despite distal-vein coverage. For an intermediate-probability patient, an adequate negative whole-leg study can complete the ASH pathway.
Common pitfall: Applying the intermediate-probability stopping rule to a high-probability patient can prematurely exclude DVT. Whole-leg coverage alone does not settle follow-up without the applicable probability category.
ASH VTE Guidelines: Diagnosis of Venous Thromboembolism - Hematology.org
11.How is recurrent DVT distinguished from residual post-thrombotic change?
Previously thrombosed veins can remain abnormal long after treatment, so persistent noncompressibility alone does not prove recurrence. Compare the current examination with prior images and measurements whenever available. A newly noncompressible venous segment or an increase in noncompressible diameter exceeding 4 mm supports recurrent DVT in the ASH diagnostic framework. Smaller or uncertain changes require further assessment rather than a confident label. New symptoms, examination quality, and clinical probability remain essential context.
Apply it
A patient with previous femoral DVT develops new swelling. The same segment remains partly noncompressible, but an adjacent previously normal segment is now noncompressible. Communicate the new segment as evidence supporting recurrence and compare prior images.
Common pitfall: Persistent echogenic material can be mistaken for treatment failure. Without comparison, residual scarring may be mislabeled as a new event and trigger unnecessary treatment.
ASH VTE Guidelines: Diagnosis of Venous Thromboembolism - Hematology.org
12.Why can symptoms persist after a deep vein thrombosis has resolved?
DVT can leave venous obstruction and valve damage that impair return and sustain venous hypertension. Post-thrombotic syndrome may produce chronic pain, swelling, heaviness, skin discoloration, and ulceration. These findings can persist without a newly formed clot. Establish the previous thrombotic distribution, symptom timeline, and baseline examination before interpreting a change. New or abruptly worsening symptoms still require assessment for recurrence, because a history of post-thrombotic symptoms does not exclude another acute event.
Apply it
A patient reports longstanding evening swelling and ankle pigmentation after a prior DVT. Compare symptoms and duplex findings with baseline, while investigating a newly painful increase in swelling rather than assuming every complaint is chronic.
Common pitfall: The presence of chronic venous symptoms does not prove active thrombosis, and the label post-thrombotic syndrome must not dismiss a clinically important new change.
13.What information does each CEAP component contribute?
CEAP separates clinical manifestations, etiology, anatomical distribution, and pathophysiology. The clinical component describes visible or palpable disease severity; it does not identify the affected venous system or mechanism by itself. Etiology distinguishes causes such as primary or secondary disease, anatomy locates involvement, and pathophysiology records reflux, obstruction, or both. Thus, a leg with advanced skin changes may have different underlying mechanisms from another leg in the same clinical class, requiring different diagnostic and treatment planning.
Apply it
Two patients have venous pigmentation. One has isolated superficial reflux; the other has post-thrombotic deep obstruction plus reflux. Record their shared clinical finding while preserving the different anatomical and pathophysiological components that influence treatment planning.
Common pitfall: Using a clinical class as a complete diagnosis hides whether reflux, obstruction, or both are present and can lead to treatment of an incidental vein.
ESVS 2022 Clinical Practice Guidelines on Chronic Venous Disease of the Lower Limbs
14.Which skin and ulcer findings distinguish CEAP clinical classes?
CEAP clinical classes progress from no visible signs through telangiectasias, varicose veins, edema, skin changes, healed ulcer, and active ulcer. C4a includes pigmentation or eczema; C4b includes lipodermatosclerosis or atrophie blanche. The 2020 revision recognizes corona phlebectatica as C4c. A healed venous ulcer is C5 and an active venous ulcer is C6. Recurrence notation adds information for recurrent varicose veins or recurrent active ulcers without replacing the basic clinical description.
Apply it
A patient has ankle pigmentation and a completely epithelialized previous venous ulcer. Classify the limb as C5 rather than C4a because the healed ulcer establishes the higher clinical class, and document the current absence of an open wound.
Common pitfall: Pigmentation does not establish an active ulcer. Conversely, a healed ulcer remains clinically meaningful and should not disappear from classification when the skin closes.
15.Which findings support a venous ulcer while prompting arterial assessment?
A venous ulcer commonly occurs in the gaiter region, often near the medial ankle, with edema and chronic venous skin changes. Location and appearance support a differential diagnosis but do not establish adequate arterial perfusion. Examine pulses and obtain appropriate arterial assessment before sustained compression when arterial disease is suspected. Mixed arterial and venous disease can coexist. A painful distal foot lesion, ischemic signs, or reduced pressures changes compression planning even if superficial reflux is also present.
Apply it
A patient has an irregular medial-ankle ulcer, edema, and pigmentation, but weak pedal pulses. Investigate arterial perfusion before selecting compression strength; the venous appearance does not remove the need to assess a potentially mixed ulcer.
Common pitfall: Calling every ankle wound purely venous can conceal arterial disease. Ulcer location is a discriminating clue, but it cannot establish compression safety by itself.
ESVS 2022 Clinical Practice Guidelines on Chronic Venous Disease of the Lower Limbs
16.How do ISL Stage 0 and Stage I lymphedema differ?
ISL Stage 0 describes impaired lymphatic transport without clinically evident swelling; subjective symptoms or subtle tissue changes may precede visible enlargement. Stage I includes early fluid accumulation that subsides with elevation, and pitting may occur. The distinction rests on evident swelling and its behavior, rather than limb size alone. A normal-looking limb therefore does not exclude early lymphatic dysfunction, while elevation-responsive edema should still be evaluated for venous, systemic, and medication-related causes.
Apply it
After lymph-node treatment, a patient reports heaviness without visible limb enlargement. Recognize possible Stage 0 dysfunction and arrange appropriate assessment rather than waiting for obvious swelling before acknowledging a potential lymphatic problem or documenting symptoms.
Common pitfall: Requiring visible enlargement before considering lymphedema misses Stage 0. Elevation-responsive swelling is also not specific enough to establish lymphatic disease without clinical context.
International Society of Lymphology: 2023 Consensus Document
17.Why does advanced lymphedema become less responsive to elevation?
With persistent lymphatic failure, tissue change extends beyond freely mobile fluid to fibrosis and adipose deposition. In ISL Stage II, elevation alone rarely resolves swelling; pitting may be present early and become less apparent as tissue changes progress. Stage III includes lymphostatic elephantiasis with substantial enlargement and trophic skin changes. Lack of pitting therefore does not exclude lymphedema. Stage describes tissue behavior and clinical change, not simply the measured circumference of the limb.
Apply it
A swollen leg remains enlarged overnight and has firm tissue with limited pitting. Consider established lymphatic tissue change rather than rejecting lymphedema because the examination does not resemble early, soft, elevation-responsive edema seen in other patients.
Common pitfall: Assuming all lymphedema must pit overlooks later fibrosis. A larger circumference alone also cannot distinguish lymphatic dysfunction from adipose enlargement or other causes.
International Society of Lymphology: 2023 Consensus Document
18.Which distribution and symptoms suggest lipedema rather than isolated lymphedema?
Lipedema is characterized by disproportionate, usually symmetrical adipose enlargement of the limbs, often with pain, tenderness, and easy bruising. Relative sparing of the feet is a useful clue compared with typical lower-limb lymphedema, which can involve the foot and toes. These patterns guide assessment rather than serving as absolute diagnostic rules. Lymphatic dysfunction can coexist with lipedema, so later fluid accumulation or foot involvement should prompt evaluation for an additional component.
Apply it
A patient has bilateral tender leg enlargement, easy bruising, and a sharp transition above relatively spared feet. Consider lipedema in the differential and assess for superimposed edema instead of interpreting limb size alone as lymphatic failure.
Common pitfall: Symmetry does not establish simple obesity, and foot sparing is not an absolute exclusion of combined disease. Examine tissue characteristics and symptoms as well.
International Society of Lymphology: 2023 Consensus Document · Lipedema World Alliance Delphi Consensus-Based Position Paper on the Definition and Management of Lipedema: Results from the 2023 Lipedema World Congress in Potsdam | Nature Communications
19.How does the swelling history prevent overdiagnosis of venous reflux as the cause?
Leg swelling can reflect venous hypertension, lymphatic failure, systemic disease, medication effects, or several mechanisms together. Establish onset, laterality, variation with standing and elevation, cardiopulmonary symptoms, previous thrombosis, surgery, and medication changes. Examine whether the severity and distribution fit the demonstrated venous abnormality. Bilateral swelling with systemic symptoms requires broader evaluation, while unilateral swelling may direct attention to local venous or lymphatic disease. An incidental reflux finding does not prove causation.
Apply it
A patient develops bilateral swelling after a medication change and also has limited superficial reflux. Document the timeline and systemic findings, and support assessment of medication and nonvenous causes before attributing all symptoms to the duplex abnormality.
Common pitfall: A positive reflux examination can become an anchoring diagnosis. Anatomical abnormality and symptom causation require correlation, particularly when swelling is bilateral or disproportionate.
ESVS 2022 Clinical Practice Guidelines on Chronic Venous Disease of the Lower Limbs
20.Why must superficial vein thrombosis be mapped beyond the tender lump?
A tender, erythematous superficial cord suggests superficial vein thrombosis, but the palpable abnormality may underestimate its extent. Duplex establishes the involved vein, thrombus length, proximity to the deep venous junction, and whether DVT coexists. These features change management because a short distal tributary thrombosis differs from thrombus approaching the saphenofemoral junction. Report measured anatomical relationships rather than using the word superficial as reassurance that the process cannot threaten the deep system.
Apply it
A patient presents with a tender medial-thigh cord. Trace the affected superficial vein proximally, measure the thrombus tip’s distance from the deep junction, and evaluate the deep veins rather than scanning only the painful segment.
Common pitfall: Treating superficial thrombosis as uniformly minor ignores junctional proximity and concomitant DVT. Visible redness alone cannot establish the full thrombus length or extent.
2023 SVS/AVF/AVLS Varicose Vein Clinical Practice Guidelines, Part II
21.When should symptoms suggest proximal venous outflow obstruction?
Extensive unilateral swelling, venous claudication, suprapubic or abdominal-wall collaterals, and a history of iliofemoral thrombosis raise concern for proximal outflow obstruction. Symptoms can persist despite patent femoral and popliteal veins because the limiting lesion lies higher. Duplex findings and clinical distribution determine whether abdominal or pelvic venous evaluation and additional imaging are appropriate. A focal compression seen on imaging must be correlated with symptoms; anatomical narrowing alone does not establish clinically significant disease.
Apply it
A patient describes whole-leg swelling and bursting discomfort during walking after prior iliofemoral DVT. Patent calf and thigh veins do not finish the assessment; evaluate proximal outflow and communicate the clinical suspicion for further investigation.
Common pitfall: A normal distal compression examination does not exclude pelvic obstruction. Conversely, an incidental anatomical compression should not automatically be assigned responsibility for nonspecific symptoms.
ESVS 2022 Clinical Practice Guidelines on Chronic Venous Disease of the Lower Limbs
Performance of Diagnostic Testing36%
22.How does the clinical indication determine the venous duplex protocol?
A thrombosis study asks whether veins are patent and compressible and where thrombus is present. A reflux study asks whether valves permit pathological reverse flow and which pathways transmit it. These purposes require different positioning, maneuvers, and documentation, although both use B-mode and Doppler. Confirm symptoms, laterality, prior procedures, and the clinical question before scanning. A technically competent examination can still be inadequate if it answers a different question from the one needed for care.
Apply it
An order says venous ultrasound, but the patient describes longstanding varicosities without acute symptoms. Clarify whether reflux mapping is intended before performing a supine DVT protocol that cannot adequately answer the treatment-planning question for this visit.
Common pitfall: Using one generic protocol for every venous order can miss the required physiological assessment even when all saved images are technically attractive and labeled.
AIUM Practice Parameter for a Peripheral Venous Ultrasound Examination, 2024 Revision · IAC Standards and Guidelines for Vascular Testing Accreditation — August 3, 2026
23.How should transducer frequency change with vein depth?
Higher-frequency ultrasound provides better spatial resolution but less penetration, while lower frequency improves penetration at the expense of detail. Use a high-frequency linear transducer for accessible superficial limb veins when adequate penetration is available. Deep pelvic vessels or marked tissue thickness may require lower frequency or a different transducer footprint. Select the highest frequency that reliably visualizes the target, then optimize depth, focus, and gain instead of accepting poor visualization as evidence of absent flow.
Apply it
A superficial calf vein is sharply defined with a high-frequency linear probe, but the iliac vein is not visible at that setting. Use a lower-frequency transducer and appropriate depth before deciding that the proximal segment cannot be evaluated.
Common pitfall: Maximum frequency does not always produce the best examination. A well-resolved superficial image is irrelevant if the selected setting cannot reach the vessel of interest.
AIUM Practice Parameter for a Peripheral Venous Ultrasound Examination, 2024 Revision
24.What makes a compression examination comprehensive?
A normal accessible vein should collapse completely under appropriate transducer pressure. A comprehensive compression examination follows the accessible venous course, testing at intervals of 2 cm or less rather than examining only a few named landmarks. Saved representative images document the study but do not replace continuous anatomical assessment. Evaluate paired veins and branches carefully because one patent channel does not establish that every channel is clear. Document inaccessible or inadequately visualized segments explicitly.
Apply it
The common femoral and popliteal veins compress normally, but the patient has persistent symptoms. Continue systematic assessment along the intervening deep veins and calf veins according to protocol rather than stopping after two reassuring landmark images.
Common pitfall: Representative normal images can conceal an incomplete examination. Compressibility at one level cannot exclude focal thrombus in an unexamined segment or duplicated channel.
AIUM Practice Parameter for a Peripheral Venous Ultrasound Examination, 2024 Revision
25.How should ultrasound describe uncertain thrombus age?
Acute thrombosis may expand a vein and appear relatively hypoechoic, whereas chronic post-thrombotic change may show wall-adherent material, reduced caliber, collateral channels, and partial recanalization. These features overlap and cannot reliably date every abnormality. Use terminology such as acute thrombosis, chronic post-thrombotic change, or indeterminate when appropriate, and compare previous studies. Echogenicity alone is insufficient to assign age. A clear report separates observed findings from the degree of certainty about their timing.
Apply it
A noncompressible segment contains mixed echogenic material without prior images and lacks a coherent acute or chronic pattern. Describe the abnormality and uncertain age, communicate the limitation, and avoid assigning a precise onset from brightness alone.
Common pitfall: Bright material is not automatically chronic, and dark material is not automatically acute. Overconfident dating can distort decisions about recurrence and treatment duration.
AIUM Practice Parameter for a Peripheral Venous Ultrasound Examination, 2024 Revision
26.Why is femoral vein thrombosis a deep venous finding?
The femoral vein is part of the deep venous system, despite the historical term superficial femoral vein. Current terminology avoids that misleading name because a report can otherwise be interpreted as describing superficial thrombosis. Trace the deep venous anatomy and recognize variants such as duplication. If one duplicated femoral channel is thrombosed and another is patent, the patent channel does not negate DVT. Precise vessel naming supports appropriate communication and management.
Apply it
An outside report describes clot in the superficial femoral vein. Clarify that the vessel is the femoral vein of the deep system, then review the images and communicate the DVT finding using current anatomical terminology.
Common pitfall: Interpreting superficial as a risk category in an outdated vessel name can lead to serious underestimation of a deep venous thrombotic finding and inappropriate reassurance.
AIUM Practice Parameter for a Peripheral Venous Ultrasound Examination, 2024 Revision
27.How do superficial, deep, and perforating veins differ anatomically?
Deep veins lie beneath the muscular fascia and provide the principal axial return pathways. Superficial veins lie above that fascia, with saphenous trunks occupying their characteristic fascial compartments. Perforating veins cross the muscular fascia to connect superficial and deep systems. These relationships matter when tracing reflux: a visible tributary is not necessarily a saphenous trunk, and a connecting channel is not defined by diameter alone. Establish continuity and fascial location before naming a vessel.
Apply it
A tortuous medial-thigh vessel lies outside the saphenous compartment. Trace its connections and the true great saphenous vein before labeling it, so treatment planning distinguishes a tributary from the axial superficial trunk and its reflux source.
Common pitfall: Naming vessels from skin location alone can misidentify tributaries or variants. Diameter and tortuosity do not replace tracing the vessel through its fascial relationships.
ESVS 2022 Clinical Practice Guidelines on Chronic Venous Disease of the Lower Limbs
28.Why should reflux testing use a dependent limb?
Reflux assessment requires adequate venous filling and a pressure challenge that can reveal valve failure. Standing or another accepted dependent position distends superficial veins and makes physiological reverse flow easier to assess. A fully supine examination can underfill the system and underestimate reflux or diameter. Use a safe supported position, particularly for patients at risk of falling, and document alternatives. The goal is reproducible physiological loading rather than standing at any cost.
Apply it
A frail patient becomes unsteady during standing reflux testing. Use an accepted supported dependent alternative, document the position, and maintain adequate venous filling rather than continuing an unsafe stance or switching silently to a flat supine examination.
Common pitfall: A negative supine reflux study may reflect inadequate loading. Patient safety still takes priority, and a modified position must be documented for correct interpretation.
IAC Standards and Guidelines for Vascular Testing Accreditation — August 3, 2026 · 2023 SVS/AVF/AVLS Varicose Vein Clinical Practice Guidelines, Part II
29.How do provocation maneuvers reveal venous reflux?
Distal compression or cuff inflation moves blood centrally; release creates a valve challenge that can expose reverse flow. Valsalva is useful at suitable proximal sites because increased abdominal pressure challenges proximal valve competence. Record the maneuver and measure the reverse-flow interval on spectral Doppler. The signal during compression is augmentation, whereas the relevant reflux interval follows the appropriate challenge. Inadequate effort, inconsistent compression, or poor sampling can produce misleading negative or nonreproducible results.
Apply it
A waveform shows a large forward burst during calf compression. Continue recording through release and measure any reverse flow afterward rather than interpreting the forward augmentation burst itself as evidence of valve incompetence at the sampled segment.
Common pitfall: A strong augmentation response establishes a response to the maneuver, not valve competence. The timing and direction of flow after the challenge determine reflux.
2023 SVS/AVF/AVLS Varicose Vein Clinical Practice Guidelines, Part II
30.Which reflux durations distinguish superficial from major deep-vein criteria?
The 2023 SVS/AVF/AVLS guideline defines reflux as reverse flow exceeding 500 milliseconds in superficial truncal veins, tibial veins, deep femoral veins, and perforators. For the common femoral, femoral, and popliteal veins, the criterion exceeds one second. Apply the threshold to the named segment and an adequately performed maneuver. Diameter alone does not establish reflux, and an abnormal duration at one site does not establish continuous axial reflux throughout a different venous pathway.
Apply it
A dependent study records 0.8 seconds of reverse flow in the great saphenous vein and 0.8 seconds in the femoral vein. The superficial measurement exceeds its threshold; the femoral measurement does not exceed the one-second criterion.
Common pitfall: Applying a single half-second rule to every vein overcalls major deep-vein reflux. Always pair the measured duration with the specific vessel and examination conditions.
2023 SVS/AVF/AVLS Varicose Vein Clinical Practice Guidelines, Part II
31.What defines a pathological perforator in a patient with varicose veins?
For patients with varicose veins, the 2023 guideline describes pathological perforators using both outward flow exceeding 500 milliseconds and diameter exceeding 3.5 mm on duplex. Outward flow means flow from the deep system toward the superficial system through the perforator. State the clinical context because a diagnostic definition is not an automatic treatment indication. Map the perforator’s location and relationship to symptoms, skin changes, or ulceration before assigning its clinical significance.
Apply it
A perforator measures 4.0 mm and demonstrates 0.7 seconds of outward flow. It meets the stated duplex definition in a varicose-vein assessment, but the report should also describe its location and associated disease before treatment is considered.
Common pitfall: A large perforator without qualifying outward flow does not meet both criteria. Meeting duplex criteria also does not mean every perforator requires an intervention.
2023 SVS/AVF/AVLS Varicose Vein Clinical Practice Guidelines, Part II
32.How should saphenous diameter measurements be standardized?
Venous diameter changes with hydrostatic loading, probe pressure, and the measurement site. Measure the saphenous vein with the limb dependent, using minimal pressure that avoids flattening the lumen, and document the anatomical location. Use consistent technique for comparisons and treatment planning. A value without position or location is difficult to interpret because a proximal trunk, distal trunk, and tributary may have very different dimensions. Diameter complements reflux mapping rather than substituting for it.
Apply it
A previous report lists a 6 mm saphenous diameter without location, while today’s dependent proximal-thigh measurement is 8 mm. Avoid calling this interval enlargement until measurement site, position, and technique can be compared meaningfully across examinations.
Common pitfall: A compressed transverse image can underestimate diameter. Comparing measurements from different positions or levels can create apparent disease progression without a true anatomical change.
IAC Standards and Guidelines for Vascular Testing Accreditation — August 3, 2026
33.How do color gain and velocity scale solve different imaging problems?
Color gain changes amplification of detected Doppler information, whereas velocity scale changes the displayed velocity range and sensitivity to slower flow. Too little gain may suppress real signals; too much produces noise or color outside vessel boundaries. A scale set too high can obscure slow venous flow even with adequate gain. Optimize these controls separately, using anatomy and spectral assessment to verify findings. Failure to display color is not equivalent to confirmed occlusion.
Apply it
A compressible vein shows little color with a high velocity scale. Lower the scale for slow flow, then adjust gain just below distracting noise and reassess instead of increasing gain indefinitely or reporting the vein as occluded.
Common pitfall: Increasing gain cannot reliably compensate for an inappropriate velocity scale. Excess gain may fill the region with noise while leaving the underlying sensitivity problem unresolved.
34.Why does color aliasing not automatically prove stenosis?
Aliasing occurs when a Doppler shift exceeds the system’s unambiguous sampling range, producing wraparound in the color display. A low scale chosen for slow venous flow can therefore alias during normal augmentation or a faster local signal. Raise the scale when needed and examine the vessel with spectral Doppler and anatomical imaging. Color hue represents direction relative to the transducer under the selected map; red and blue do not inherently identify arteries and veins.
Apply it
A vein develops mixed colors only during a forceful distal squeeze. Increase the scale and obtain a localized spectral waveform before assigning stenosis, because the transient flow burst may simply exceed the original low sampling range.
Common pitfall: A color mosaic is a display clue, not a diagnosis. Its meaning depends on scale, flow conditions, vessel anatomy, and corroborating spectral information.
35.How does the color region of interest affect frame rate?
A larger color region requires more sampling and processing, which can reduce frame rate and make brief flow changes harder to appreciate. Restrict the region to the anatomy needed for the question, particularly when timing reflux or following a small vessel. Excess depth also adds unnecessary work. A narrow region should still include enough surrounding anatomy to maintain orientation. Image optimization balances temporal resolution, anatomical context, and sensitivity rather than maximizing every display dimension.
Apply it
A large color box covers the entire thigh image and flow updates sluggishly. Reduce its width and depth around the target vein, maintain the necessary anatomical landmarks, and reassess the maneuver with improved temporal resolution before interpretation.
Common pitfall: A larger color box may look comprehensive while reducing useful temporal detail. Shrinking it too far can also remove landmarks needed to identify the vessel.
36.Why does Doppler beam alignment affect the measured flow signal?
Doppler detects a frequency difference between transmitted and received sound from moving reflectors. The shift depends partly on the cosine of the angle between the beam and flow direction. Near a right angle, the detectable shift becomes very small despite real flow. Reposition or steer the beam to obtain useful alignment. If calculating velocity, align angle correction with the actual flow direction; an incorrect correction changes the reported velocity without changing the blood’s motion.
Apply it
Color is weak in a longitudinal vein segment where the beam is nearly perpendicular to flow. Adjust probe orientation or steering and repeat the assessment before concluding that the vein has minimal or absent blood flow at that site.
Common pitfall: Changing angle correction edits the velocity calculation; it does not improve the underlying beam-flow interaction. Acquisition alignment must be addressed when the signal is poor.
37.How does the spectral sample volume localize a venous measurement?
Pulsed-wave Doppler samples returning signals from a selected depth and region. Place the sample volume within the intended vein and verify its location on the image, especially near an adjacent artery or junction. The spectral display plots time horizontally and Doppler-derived frequency or velocity vertically, with direction relative to baseline. A misplaced or oversized gate can mix signals from neighboring vessels, creating a convincing waveform that answers the wrong anatomical question.
Apply it
A waveform labeled femoral vein appears strongly arterial. Check the sample-volume position and size relative to the neighboring artery, reposition within the venous lumen, and reacquire the tracing before diagnosing abnormal venous pulsatility or an arteriovenous connection.
Common pitfall: A clean spectral tracing does not guarantee correct vessel sampling. Always verify gate location and correlate the waveform with B-mode anatomy and color flow.
38.How do respiratory phasicity and augmentation provide different information?
Respiratory variation in lower-extremity venous flow reflects transmitted pressure changes and supports assessment of proximal outflow. Marked side-to-side asymmetry or continuous flow can suggest a proximal obstruction, although technique and patient physiology must be considered. Distal augmentation tests the response to a pressure impulse from below. Neither a normal augmentation response nor visible flow excludes all thrombus. Interpret waveforms with compression findings, bilateral comparison, and the anatomical territory actually examined.
Apply it
The left common femoral waveform is persistently continuous while the right is respiratory phasic under comparable conditions. Confirm technique and investigate proximal left-sided outflow rather than accepting a normal calf-squeeze response as proof that the entire pathway is normal.
Common pitfall: Augmentation and respiratory phasicity are not interchangeable patency tests. A single reassuring waveform feature cannot compensate for an abnormal comparison or an incomplete anatomical examination.
AIUM Practice Parameter for a Peripheral Venous Ultrasound Examination, 2024 Revision · ESVS 2022 Clinical Practice Guidelines on Chronic Venous Disease of the Lower Limbs
39.When should abdominopelvic duplex be supplemented by other imaging?
Abdominal and pelvic veins can be difficult to evaluate because of depth, bowel gas, body habitus, and complex collateral pathways. Duplex can assess accessible segments, flow patterns, and indirect signs of obstruction, but a limited view is not a negative examination. When clinical suspicion for suprainguinal disease remains and intervention is being considered, cross-sectional venous imaging can clarify anatomy. Report the actual limitation and its consequences so the next test addresses the unresolved question.
Apply it
A patient has whole-leg edema and abnormal common femoral phasicity, but bowel gas obscures the iliac vein. Document the nonvisualized segment and persistent concern, supporting additional venous imaging rather than reporting the pelvic outflow as normal.
Common pitfall: No visible lesion is different from adequate visualization without a lesion. Technical limitations must remain visible in the interpretation rather than becoming an implied normal result.
ESVS 2022 Clinical Practice Guidelines on Chronic Venous Disease of the Lower Limbs
40.How is upper-extremity venous assessment adapted at the clavicle?
The clavicle limits direct compression of the subclavian vein, so a comprehensive upper-extremity examination combines compression where accessible with color and spectral Doppler where it is not. Assess the internal jugular, axillary, brachial, and relevant superficial veins according to the clinical question and protocol. Catheter history and collateral veins can increase concern for central obstruction. Bilateral waveform comparison can provide indirect information, but normal accessible arm segments do not fully exclude a central lesion.
Apply it
A patient with a central catheter has arm swelling. Compress accessible veins, evaluate the subclavian segment with Doppler, compare waveforms, and document any central limitation rather than declaring the whole examination negative because the brachial veins compress.
Common pitfall: Failure to compress beneath the clavicle is an anatomical limitation, not itself proof of thrombosis. Conversely, compressible peripheral veins do not guarantee normal central outflow.
AIUM Practice Parameter for a Peripheral Venous Ultrasound Examination, 2024 Revision
41.What makes an abnormal venous report clinically actionable?
An actionable report identifies side, named vessel, anatomical extent, relevant measurements, examination limitations, and the findings that answer the clinical question. For thrombosis, describe the involved segments and relationships that affect management; for reflux, identify the source and distribution rather than merely saying positive. Urgent or unexpected findings require timely communication through the laboratory’s established process, with documentation of whom was notified. Image labels and the narrative should agree so subsequent clinicians can reconstruct the result.
Apply it
A scan identifies new proximal DVT. Record the involved segments and limitations, promptly notify the responsible clinician through the urgent-results process, and document the communication instead of relying solely on a report awaiting routine review later.
Common pitfall: A technically accurate report can still fail the patient if an urgent result is delayed or if vague wording conceals the vessel, extent, or limitations.
IAC Standards and Guidelines for Vascular Testing Accreditation — August 3, 2026 · AIUM Practice Parameter for a Peripheral Venous Ultrasound Examination, 2024 Revision
42.How is ALARA applied during diagnostic venous ultrasound?
ALARA means keeping acoustic exposure as low as reasonably achievable while obtaining the necessary diagnostic information. Optimize receiver settings and technique before increasing acoustic output unnecessarily, minimize dwell time, and monitor displayed thermal and mechanical indices. These indices support awareness of potential thermal and mechanical effects; they are not guarantees that any exposure is harmless. Efficient acquisition and clinically justified scanning reduce exposure without sacrificing the measurements needed to answer the indication.
Apply it
A difficult vein produces a weak image. Adjust depth, focus, frequency, and patient position before raising output, then acquire the required information efficiently rather than leaving an optimized beam stationary while discussing unrelated matters with colleagues.
Common pitfall: Low output alone does not complete ALARA if exposure is unnecessarily prolonged. Diagnostic quality and exposure duration must be considered together with displayed safety indices.
AIUM: Prudent Clinical Use and Safety of Diagnostic Ultrasound
43.How does reflux mapping identify the correct treatment target?
Reflux mapping traces abnormal flow to its source and documents its pathway through junctions, trunks, tributaries, and relevant perforators. A dilated visible varicosity may receive reflux from a separate axial vein, pelvic source, or recurrent connection. Record the length and distribution of truncal reflux, vein course, depth, and connections that affect access and safety. Segmental reflux differs from uninterrupted axial reflux, and treatment planning should preserve that distinction instead of treating every enlarged vein identically.
Apply it
A recurrent thigh varicosity connects to a refluxing tributary while the previously treated great saphenous trunk remains closed. Map the actual connection and source so planning addresses the recurrent pathway rather than automatically retreating the closed trunk.
Common pitfall: The most visible vein is not necessarily the source. Mapping only the symptomatic cluster can miss the pathway sustaining it and produce an incomplete treatment plan.
2023 SVS/AVF/AVLS Varicose Vein Clinical Practice Guidelines, Part II
Conservative Treatment/Therapy of Patients9%
44.How does graduated compression support venous return?
Graduated medical compression applies greater pressure at the ankle than more proximally, countering dependent venous hypertension and supporting fluid return. Appropriate fit and pressure selection matter because a poorly fitted garment can be ineffective or create focal constriction. Compression can reduce symptoms and edema, but it does not eliminate an underlying reflux pathway. Assess arterial safety and the patient’s ability to apply and tolerate the device, then reassess skin condition and clinical response.
Apply it
A patient’s stocking rolls into a tight band below the knee and swelling persists. Reassess sizing, application technique, and the compression plan rather than assuming the disease simply requires a stronger garment regardless of fit and skin response.
Common pitfall: More pressure is not automatically better. A garment that bunches, constricts, or cannot be applied consistently may fail despite an appropriate nominal compression class.
ESVS 2022 Clinical Practice Guidelines on Chronic Venous Disease of the Lower Limbs
45.When does arterial disease change sustained compression planning?
Compression can reduce perfusion when significant arterial insufficiency limits pressure reaching the limb. ESVS advises against sustained compression for active venous ulceration when ankle pressure is below 60 mmHg, toe pressure below 30 mmHg, or ABI below 0.6. Selected mixed-disease patients above these boundaries may receive modified compression with close supervision. A noncompressible ankle artery can make ABI misleading, requiring another perfusion assessment rather than accepting an apparently high ABI as reassurance.
Apply it
A patient with a venous-appearing ulcer has an ankle pressure of 52 mmHg. Avoid routine sustained compression and arrange arterial evaluation, because the measured perfusion falls below the guideline boundary despite clear evidence of venous disease.
Common pitfall: Venous reflux does not neutralize arterial risk. An elevated ABI from noncompressible arteries also cannot establish adequate tissue perfusion or automatically justify high compression.
ESVS 2022 Clinical Practice Guidelines on Chronic Venous Disease of the Lower Limbs
46.How do exercise and other conservative measures address venous symptoms and lipedema?
Calf contraction compresses deep veins, ankle mobility supports the venous pump, and elevation reduces dependent hydrostatic loading. Tolerable walking, ankle exercise, weight management when relevant, and elevation can complement compression for chronic venous symptoms. In lipedema, individually fitted compression and tailored exercise aim to reduce pain or heaviness and improve mobility and function. Address relevant comorbid obesity, lymphatic or venous disease, joint limitations, and psychological distress. These measures provide symptom management; they do not remove the abnormal adipose tissue. Treat coexisting obesity as a separate condition without promising that weight loss will eliminate lipedema symptoms.
Apply it
A patient with tender lipedema tissue and limited walking tolerance starts tolerable low-impact exercise and fitted compression. Track pain and walking ability, address joint and weight-related problems, and explain why improved function can occur without elimination of disproportionate limb fat.
Common pitfall: Elevation response does not establish a venous diagnosis. In lipedema, persistent limb disproportion does not by itself show conservative treatment failure when pain, activity, or quality of life improves.
ESVS 2022 Clinical Practice Guidelines on Chronic Venous Disease of the Lower Limbs · Lipedema World Alliance Delphi Consensus-Based Position Paper on the Definition and Management of Lipedema: Results from the 2023 Lipedema World Congress in Potsdam | Nature Communications
47.How do intensive and maintenance decongestive treatment differ?
Complete decongestive therapy combines skin care, exercise, compression, and manual lymphatic drainage as appropriate. The intensive phase aims to reduce accumulated fluid and commonly uses multilayer compression bandaging. Maintenance preserves that reduction with fitted compression garments, continued skin care and exercise, and additional drainage when needed. Lymphatic dysfunction persists after a successful volume reduction, so stopping all measures invites reaccumulation. Treatment also needs realistic self-management education and monitoring for skin complications.
Apply it
After intensive therapy, a patient’s limb volume decreases substantially. Arrange a fitted maintenance garment and ongoing skin care and exercise rather than ending treatment entirely once the measured circumference approaches the initial goal established with the treating team.
Common pitfall: Successful decongestion does not restore normal lymphatic transport in every patient. Treating the reduction as a cure can lead to recurrent swelling and preventable skin problems.
International Society of Lymphology: 2023 Consensus Document
48.How should medication selection follow the venous or lymphatic mechanism?
For superficial thrombosis of an above-knee main saphenous trunk or tributary measuring at least 5 cm and lying more than 3 cm from the saphenofemoral junction, the 2023 guideline recommends fondaparinux 2.5 mg subcutaneously daily for 45 days; rivaroxaban 10 mg daily for 45 days is an alternative when injections are unsuitable. Main-trunk thrombus within 3 cm of the junction follows a full-anticoagulation strategy for at least six weeks. Coexisting DVT changes the pathway. Before prescribing, assess bleeding risk, renal function, interacting medicines, and contraindications. By contrast, long-term diuretics have limited benefit for isolated lymphedema and can cause fluid or electrolyte imbalance because they do not restore lymphatic transport. A separate systemic condition may still justify a diuretic.
Apply it
Duplex shows a 7 cm above-knee great saphenous thrombus whose tip is 4 cm from the junction, without DVT. These measurements support consideration of the 45-day regimen after bleeding and medication review. A tip 2 cm from the junction changes the anticoagulation strategy.
Common pitfall: Local symptom relief alone does not address thromboembolic risk in extensive superficial thrombosis. Conversely, a diuretic prescribed for systemic overload should not be stopped merely because it cannot correct lymphatic failure.
2023 SVS/AVF/AVLS Varicose Vein Clinical Practice Guidelines, Part II · International Society of Lymphology: 2023 Consensus Document
Minimally Invasive and Invasive Treatment of Patients20%
49.What must consent and the procedural time-out establish?
Informed consent requires an understandable discussion of the proposed procedure, expected benefits, material risks, and viable alternatives, with an opportunity for questions and documentation appropriate to the setting. A signed form alone does not establish understanding. Immediately before an invasive procedure, the team verifies identity, intended procedure, and site during the time-out. Consent and the time-out serve different functions: the first supports an informed choice, while the second prevents a mismatch at execution.
Apply it
A patient signed a consent form for left-leg ablation, but the prepared tray and marking indicate the right leg. Stop before puncture, reconcile the intended treatment with the patient and records, and complete a corrected team time-out.
Common pitfall: A signature does not resolve uncertainty about what the patient understood, and a correctly completed consent form cannot replace immediate verification of the intended procedural site.
AIUM Practice Parameter for Ultrasound-Guided Procedures · AIUM: Policies and Procedures Safeguarding Patients and Personnel
50.Why must the needle tip remain identifiable during ultrasound guidance?
Real-time ultrasound guidance depends on knowing where the needle tip is relative to the target and nearby structures. A bright shaft or cross-sectional needle echo does not always identify the tip. Optimize the imaging plane and advance in controlled increments while confirming tip position. If the tip is lost, stop advancement or injection and re-establish visualization. This principle applies whether using an in-plane or out-of-plane approach and reduces unintended vessel, nerve, or tissue injury.
Apply it
During venous access, a bright linear echo remains visible but the distal tip disappears. Pause advancement, adjust the probe and needle relationship, and identify the tip relative to the vein before progressing or injecting any material through the needle.
Common pitfall: Seeing part of the needle can create false confidence. The visible shaft may cross the target while the unseen tip has already passed beyond it.
51.How does polidocanol close a treated superficial vein?
Polidocanol is a detergent sclerosant that damages venous endothelium, leading to local thrombosis and eventual fibrous obliteration of the treated lumen. The intended effect depends on delivery into the selected vein, so correct identification and careful injection are central to safety. The US Asclera label addresses uncomplicated lower-extremity spider and reticular veins within its specified diameter range. That label should not be assumed to authorize every foam preparation, target vessel, or treatment technique.
Apply it
A patient asks why a sclerosant differs from an anticoagulant. Explain that the injected agent intentionally injures the target vein’s lining to close it, whereas anticoagulation addresses clot formation through a different mechanism and clinical purpose.
Common pitfall: Calling all venous injections interchangeable hides differences in drug formulation, labeled indication, and mechanism. A product label cannot be generalized to every sclerotherapy method.
Asclera (Polidocanol) Prescribing Information — January 2025
52.Which injection findings suggest sclerosant-related tissue or arterial injury?
Extravasated sclerosant can injure surrounding tissue, and intra-arterial injection can cause severe ischemia, necrosis, or gangrene. Unexpected severe pain, blanching, or signs of impaired distal perfusion during injection require immediate cessation and urgent assessment. Confirm intravascular positioning and use appropriate imaging when indicated. A visible superficial target does not eliminate arterial proximity or guarantee correct needle placement. The response should address possible tissue-threatening injury rather than treating the reaction as expected cosmetic discomfort.
Apply it
During a planned superficial injection, the patient reports abrupt severe pain and the skin blanches. Stop injection immediately, assess circulation and needle location, and obtain urgent medical evaluation rather than completing the planned volume despite the new warning signs.
Common pitfall: Continuing slowly is not a safe response to possible arterial injection. Severe pain and blanching require reassessment before any further administration into the target.
Asclera (Polidocanol) Prescribing Information — January 2025
53.How does tumescent anesthesia protect tissues during thermal ablation?
Ultrasound-guided tumescent fluid around the vein provides local anesthesia, compresses the vein around the thermal device, and separates the vein from nearby skin and nerves. The surrounding fluid also acts as a heat sink. Confirm circumferential distribution and the relationship to vulnerable structures before energy delivery. Nonthermal methods have different technical requirements and may avoid tumescence, but they introduce their own material-specific or drug-specific considerations. Treatment selection depends on anatomy, symptoms, and procedural risks.
Apply it
Before thermal treatment of a superficial segment close to the skin, imaging shows an incomplete fluid envelope. Improve the tumescent distribution and separation before energy delivery instead of relying solely on the patient reporting that the area feels numb.
Common pitfall: Analgesia is only one tumescent function. A numb patient can still have inadequate thermal separation, particularly near skin or nerves along the treatment segment.
ESVS 2022 Clinical Practice Guidelines on Chronic Venous Disease of the Lower Limbs
54.How should recurrent symptoms after open venous surgery be evaluated?
Previous ligation or stripping changes anatomy but does not exclude residual reflux, recurrent connections, disease progression, or complications. Establish the operation performed, side, timing, and postoperative course, then correlate examination findings with duplex mapping. Early concerns include wound problems and thrombosis; later recurrent varicosities require identification of their actual source. A scar or absent expected trunk should be interpreted in the surgical context. Recurrence should not be assigned to a presumed mechanism without tracing the pathway.
Apply it
Years after saphenous surgery, a patient develops new groin-to-thigh varicosities. Review the operative history and map residual trunks, tributaries, and junctional connections before planning treatment, rather than assuming that the original great saphenous vein has simply reopened.
Common pitfall: Prior surgery does not establish current anatomy. Treating every recurrent varicosity as the same original lesion can miss residual branches, new pathways, or deep disease.
ESVS 2022 Clinical Practice Guidelines on Chronic Venous Disease of the Lower Limbs
55.How do phlebectomy and axial ablation address different parts of reflux disease?
Phlebectomy removes selected superficial varicose tributaries through small incisions, whereas axial ablation closes a refluxing truncal pathway. A patient may need treatment of both a reflux source and symptomatic tributaries, either together or in stages according to the clinical plan. Ultrasound mapping determines whether the visible cluster receives reflux from a trunk, perforator, or other source. Removing a tributary does not automatically eliminate the mechanism feeding remaining veins, and truncal closure may leave residual symptomatic branches.
Apply it
Duplex shows great saphenous axial reflux feeding a painful calf cluster. Explain why the plan may combine truncal treatment with tributary treatment, while using mapped connections and patient preference to determine whether these are performed together or in stages.
Common pitfall: Treating the visible cluster alone may leave its reflux source. Conversely, technically successful truncal closure does not guarantee that every symptomatic tributary has resolved.
2023 SVS/AVF/AVLS Varicose Vein Clinical Practice Guidelines, Part II
56.Which findings support consideration of deep venous intervention?
Deep venous intervention requires a clinically important problem that matches the demonstrated anatomy, such as severe symptoms associated with iliac outflow obstruction. Imaging evidence alone is insufficient because anatomical compression can occur without significant symptoms. Preprocedure evaluation establishes symptom burden, prior thrombosis, inflow and outflow, and existing treatment. Postprocedure assessment examines patency, symptom change, access-site problems, and thrombotic complications. A technically successful intervention must still be judged against the patient’s original clinical problem.
Apply it
Imaging shows iliac narrowing in a patient with minimal nonspecific symptoms. Avoid equating that image with an automatic stent indication; correlate symptoms and hemodynamic evidence, and document baseline function before a specialist determines whether intervention is justified.
Common pitfall: Anatomical narrowing and clinically significant obstruction are not synonymous. A normal-looking treated segment also cannot substitute for assessment of inflow, outflow, complications, and symptom response.
ESVS 2022 Clinical Practice Guidelines on Chronic Venous Disease of the Lower Limbs
57.When is postablation thrombosis assessment especially important?
Ablation-related thrombus extension describes thrombus extending toward or into the deep system after venous ablation. The 2023 guideline recommends early duplex for symptomatic patients and supports early assessment in high-risk patients. It advises against routine early duplex solely to screen an asymptomatic average-risk patient after thermal ablation. Risk stratification also informs selective prophylaxis. New swelling or pain requires assessment, while dyspnea or chest pain warrants emergency evaluation rather than waiting for a scheduled surveillance visit.
Apply it
Five days after thermal ablation, a patient reports new swelling and calf pain. Arrange prompt clinical and duplex assessment despite a low-risk preprocedure history, and provide emergency instructions if chest pain or breathing difficulty develops before evaluation.
Common pitfall: Guidance against routine screening in one low-risk asymptomatic group does not apply to new symptoms. A scheduled follow-up date should never delay urgent reassessment.
2023 SVS/AVF/AVLS Varicose Vein Clinical Practice Guidelines, Part II
58.How should venous stent duplex cover the entire treated pathway?
Venous stent assessment should document proximal, middle, and distal stent segments and native vein adjacent to both ends. Evaluate lumen appearance and flow throughout, including inflow and outflow, rather than recording one reassuring central waveform. Compare with prior examinations and the clinical presentation. Focal abnormalities, absent flow, or changes in surrounding segments may require further assessment. A complete study also states technical limitations, because deep location can restrict visualization of parts of the treated pathway.
Apply it
A patient with an iliac stent develops recurrent swelling. Acquire images and Doppler throughout the stent and adjacent native veins, compare baseline findings, and report any nonvisualized portion rather than relying on a patent mid-stent color image alone.
Common pitfall: Flow in the middle of a stent does not prove normal inflow or outflow. A limited sampling strategy can miss disease at either end.
IAC Standards and Guidelines for Vascular Testing Accreditation — August 3, 2026
59.How is revised VCSS scored and interpreted over time?
Revised VCSS scores ten components: pain, varicose veins, venous edema, pigmentation, inflammation, induration, active ulcer number, active ulcer duration, active ulcer size, and compression use. Each receives 0–3 points; the total is 0–30 per limb. Clinical attributes use component-specific definitions progressing from absent to more severe disease. Pain grading reflects frequency and activity limitation; edema and skin findings reflect anatomical extent. Active ulcer number scores 0 for none, 1 for one, 2 for two, and 3 for three or more. Ulcer duration and size are graded separately, with no active ulcer scoring 0. Compression scores 0 for no use, 1 for intermittent use, 2 for use most days, and 3 for full compliance. Thus, improved compression adherence increases that component without necessarily indicating worse disease. Record component scores alongside the total and use consistent definitions at follow-up.
Apply it
At baseline, pain 2, varicosities 2, edema 2, pigmentation 1, compression 1, and all other components 0 total 8. At follow-up, pain 1, varicosities 0, edema 1, pigmentation 1, compression 3, and the others 0 total 6. Clinical components improved from 7 to 3, while better compression adherence added two points; the total alone understates the clinical improvement.
Common pitfall: Anatomical closure does not establish clinical benefit, and a higher compression score does not mean more severe disease. Compare individual components, patient-reported function, and the total rather than interpreting any total change in isolation.
Revision of the Venous Clinical Severity Score — AVF Consensus Statement
60.Which population and treatment timing support the EVRA conclusion?
EVRA enrolled adults with active venous ulcers approximately six weeks to six months old, an ankle–brachial pressure index of at least 0.8, ability to tolerate compression, and superficial reflux suitable for endovenous ablation. Early treatment meant ablation within two weeks of randomization, alongside compression. The comparison group received compression with ablation deferred until healing or six months if the ulcer remained unhealed. Early ablation accelerated healing. These are trial eligibility and timing criteria, not universal restrictions on all ulcer treatment. Applying the result requires assessment of ulcer cause, arterial perfusion, reflux anatomy, and the accompanying compression and wound-care plan.
Apply it
An adult with a 12-week venous ulcer, ABPI 0.9, compression tolerance, and suitable superficial reflux resembles the studied population. Discuss early ablation alongside compression. A patient outside these trial criteria requires separate assessment of the evidence and treatment options rather than automatic exclusion from care.
Common pitfall: An open ulcer does not always require deferring reflux treatment. Conversely, EVRA does not establish that every ulcer is venous, remove the need for arterial assessment, or justify stopping compression after ablation.
Early versus Deferred Endovenous Ablation: The EVRA Randomized Controlled Trial
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Use the present CCI outline as the full study map; emphasize diagnostic testing and patient diagnosis while retaining safety, conservative care, and intervention knowledge.
- Distinguish intermediate- from high-probability DVT pathways, proximal-only from whole-leg assessment, residual post-thrombotic change from recurrence, and a positive D-dimer from a confirmed diagnosis.
- Practise dependent reflux acquisition, vessel-specific duration criteria, perforator characterization, and mapping of the actual reflux source.
- Link physics controls to specific image problems: penetration, beam alignment, color sensitivity, aliasing, gate placement, and frame rate.
- Correlate edema, ulceration, CEAP findings, lymphatic stages, and arterial perfusion before assigning cause or selecting compression. Include lipedema symptom management and anatomy-based anticoagulation decisions.
- Connect procedural anatomy with sterile technique, needle-tip control, thermal protection, thrombosis assessment, and measurable clinical outcomes.
A practical preparation plan
1. Build the official scope map
Read the present CCI task and knowledge lists, then map each task to your experience. Mark unpractised areas such as pelvic duplex, upper-extremity assessment, or postoperative evaluation for additional study. Extend study beyond these selected concepts to detailed BLS, information security, mathematical and statistical applications, and catheter-directed treatment techniques.
2. Construct diagnostic pathways
Work through suspected first DVT, suspected recurrence, chronic swelling, superficial thrombosis, and ulcer cases. State pretest probability, the required examination, the meaning of a negative result, and the finding that changes the next step.
3. Rehearse acquisition and interpretation
Explain each positioning choice, compression segment, Doppler maneuver, setting change, and reflux measurement. Compare complete studies with technically limited ones and write a concise report that preserves the limitation.
4. Pair treatment with mechanism and risk
For compression, decongestion, lipedema symptom management, anticoagulation, sclerotherapy, ablation, surgery, and stenting, identify the problem addressed, essential pretreatment assessment, major complication cue, and appropriate clinical outcome.
5. Review errors by reasoning
Complete the 20 questions before reading explanations. For each error, identify the missed cue and explain why all alternative options fail. Revisit weak domains with the flashcards and the cited primary references.
6. Prepare for the actual examination
Confirm your applicable CCI blueprint and testing dates, review the listed innovative item instructions, and practise steady pacing. Use these drills to locate learning gaps while continuing study across the full official outline.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- Registered Phlebology Sonographer (RPhS) — CCI
- Registered Phlebology Sonographer Examination Overview — June 2022
- CDC Recommendations for Disinfection and Sterilization in Healthcare Facilities
- OSHA Hospital eTool: Sonography
- CDC: About Venous Thromboembolism
- AIUM Practice Parameter for a Peripheral Venous Ultrasound Examination, 2024 Revision
- ASH Clinical Practice Guidelines: Diagnosis of Venous Thromboembolism
- ASH: Testing for Blood Clots — Patient Version
- International Society of Lymphology: 2023 Consensus Document
- IAC Standards and Guidelines for Vascular Testing Accreditation — August 3, 2026
- ESVS 2022 Clinical Practice Guidelines on Chronic Venous Disease of the Lower Limbs
- GE HealthCare: Color Imaging Scanning Adjustments
- GE HealthCare: Pulsed Wave Spectral Doppler
- 2023 SVS/AVF/AVLS Varicose Vein Clinical Practice Guidelines, Part II
- Asclera (Polidocanol) Prescribing Information — January 2025
- AIUM Practice Parameter for Ultrasound-Guided Procedures
- Early versus Deferred Endovenous Ablation: The EVRA Randomized Controlled Trial
- CDC: Clinical Safety — Hand Hygiene for Healthcare Workers
- CDC: Burkholderia Infections Associated with Contaminated Ultrasound Gel
- AIUM: Prudent Clinical Use and Safety of Diagnostic Ultrasound
- Revision of the Venous Clinical Severity Score — AVF Consensus Statement
- American Venous Forum: Revised CEAP
- AIUM: Policies and Procedures Safeguarding Patients and Personnel
- ASH VTE Guidelines: Diagnosis of Venous Thromboembolism - Hematology.org
- Optimising PW Doppler settings : Vscan Air ™
- MKT03477%20Ultrasound%20Physics%20and%20Terminology%20Rev%201.0.pdf
- Lipedema World Alliance Delphi Consensus-Based Position Paper on the Definition and Management of Lipedema: Results from the 2023 Lipedema World Congress in Potsdam | Nature Communications
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.